{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T01:47:52Z","timestamp":1722995272142},"posted":{"date-parts":[[2023,5,18]]},"group-title":"In Review","reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,10]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Objective:<\/bold> There has been no previous systematic, epidemiological study of the reproductive risk factors for uterine fibroids (UF) in African populations despite African women having the highest burden of UF in the world. Improved knowledge of the associations between UF and reproductive factors would contribute to better understanding of the etiology of UF and may suggest novel opportunities for prevention and therapeutic interventions.\n<bold>Design:<\/bold> We used nurse administered questionnaires to survey the demographic and reproductive risk factors of UF among 484 women who are members of the African Collaborative Center for Microbiome and Genomics Research (ACCME) Study Cohort in central Nigeria, and who had transvaginal ultrasound diagnosis (TVUS). We used logistic regression models to the evaluate associations between reproductive risk factors and UF, adjusted for significant covariates.\n<bold>Results: <\/bold>In our multivariable logistic regression models, we found inverse associations with number of children (OR = 0.83, 95%CI = 0.74-0.93, p-value = 0.002), parity (OR = 0.41, 95%CI = 0.24-0.73, p-value = 0.002), history of any type of abortion (OR = 0.53, 95%CI = 0.35-0.82, p-value = 0.004), duration of use of Depot Medroxyprogesterone Acetate (DMPA) (p-value for trend = 0.02), menopausal status (OR = 0.48, 95%CI = 0.27-0.84, p-value = 0.01), and a non-linear positive association with age (OR = 1.04, 95%CI = 1.01-1.07, p-value = 0.003). Other reproductive risk factors that have been reported in other populations (age at menarche and menopause, and oral contraceptives) were not associated with UF in this study.\n<bold>Conclusion:<\/bold> Our study confirms the reproductive risk factors for UF that have been found in other populations and shows that some of them are stronger in the Nigerian population. The associations we found with DMPA suggest opportunities for further research to understand the mechanisms of action of progesterone and its analogues in the etiology of UF, their potential use for prevention and treatment of UF.<\/p>","DOI":"10.21203\/rs.3.rs-2917100\/v1","type":"posted-content","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:51:59Z","timestamp":1684399919000},"source":"Crossref","is-referenced-by-count":0,"title":["Population-based study of the reproductive risk factors for Transvaginal Ultrasound diagnosed Uterine Fibroids in Nigerian women"],"prefix":"10.21203","author":[{"given":"Clement A.","family":"Adebamowo","sequence":"first","affiliation":[{"name":"University of Maryland School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally N.","family":"Adebamowo","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the ACCME Research Group as part of the H3Africa Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart EA","year":"2017","unstructured":"Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG: an international journal of obstetrics and gynaecology 2017; 124(10): 1501\u201312.","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"e052053","DOI":"10.1136\/bmjopen-2021-052053","article-title":"Epidemiology of uterine fibroid in black African women: a systematic scoping review","volume":"12","author":"Morhason-Bello IO","year":"2022","unstructured":"Morhason-Bello IO, Adebamowo CA. Epidemiology of uterine fibroid in black African women: a systematic scoping review. BMJ Open 2022; 12(8): e052053.","journal-title":"BMJ Open"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36313-y","article-title":"Validation of Self-Report of Uterine Fibroid Diagnosis using a Transvaginal Ultrasound Scan","author":"Adebamowo AC","year":"2023","unstructured":"Adebamowo AC, Morhason-Bello IO, the ACCME Research Group as part of the H3Africa Consortium, Adebamowo SN. Validation of Self-Report of Uterine Fibroid Diagnosis using a Transvaginal Ultrasound Scan. Scientific Reports 2023; in press.","journal-title":"Scientific Reports"},{"key":"ref4","first-page":"1","article-title":"A clinical audit of the patterns of presentations and complications of abdominal myomectomy at the University College Hospital, Ibadan, Nigeria","author":"Agboola AD","year":"2021","unstructured":"Agboola AD, Bello OO, Olayemi OO. A clinical audit of the patterns of presentations and complications of abdominal myomectomy at the University College Hospital, Ibadan, Nigeria. J Obstet Gynaecol 2021: 1\u20136.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"101631","DOI":"10.1016\/j.jogoh.2019.101631","article-title":"Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma","volume":"49","author":"Yorganc\u0131 A","year":"2020","unstructured":"Yorganc\u0131 A, Meydanl\u0131 MM, Kad\u0131o\u011flu N, et al. Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma. J Gynecol Obstet Hum Reprod 2020; 49(1): 101631.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00404-016-4239-y","article-title":"Symptoms of uterine myomas: data of an epidemiological study in Germany","volume":"295","author":"Foth D","year":"2017","unstructured":"Foth D, Rohl FW, Friedrich C, et al. Symptoms of uterine myomas: data of an epidemiological study in Germany. Arch Gynecol Obstet 2017; 295(2): 415\u201326.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/GRF.0000000000000164","article-title":"Epidemiology of Uterine Fibroids: From Menarche to Menopause","volume":"59","author":"Wise LA","year":"2016","unstructured":"Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin Obstet Gynecol 2016; 59(1): 2\u201324.","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird DD","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188(1): 100\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2017.09.004","article-title":"Epidemiology and Risk Factors of Uterine Fibroids","volume":"46","author":"Pavone D","year":"2018","unstructured":"Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology 2018; 46: 3\u201311.","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.fertnstert.2010.04.065","article-title":"Reproductive characteristics and risk of uterine leiomyomata","volume":"94","author":"Terry KL","year":"2010","unstructured":"Terry KL, De Vivo I, Hankinson SE, Missmer SA. Reproductive characteristics and risk of uterine leiomyomata. Fertility and Sterility 2010; 94(7): 2703\u20137.","journal-title":"Fertility and Sterility"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0015-0282(98)00208-8","article-title":"A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata","volume":"70","author":"Marshall LM","year":"1998","unstructured":"Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertility and sterility 1998; 70(3): 432\u20139.","journal-title":"Fertility and sterility"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2015.11.018","article-title":"The Epidemiology and Genetics of Uterine Leiomyoma","volume":"34","author":"Styer AK","year":"2016","unstructured":"Styer AK, Rueda BR. The Epidemiology and Genetics of Uterine Leiomyoma. Best practice & research Clinical obstetrics & gynaecology 2016; 34: 3\u201312.","journal-title":"Best practice & research Clinical obstetrics & gynaecology"},{"issue":"4","key":"ref13","first-page":"424","article-title":"Epidemiology of Uterine Myomas: A Review","volume":"9","author":"Sparic R","year":"2016","unstructured":"Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of Uterine Myomas: A Review. Int J Fertil Steril 2016; 9(4): 424\u201335.","journal-title":"Int J Fertil Steril"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.EDE.0000054360.61254.27","article-title":"Why is parity protective for uterine fibroids?","volume":"14","author":"Baird DD","year":"2003","unstructured":"Baird DD, Dunson DB. Why is parity protective for uterine fibroids? Epidemiology 2003; 14(2): 247\u201350.","journal-title":"Epidemiology"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study","volume":"159","author":"Wise LA","year":"2004","unstructured":"Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 2004; 159(2): 113\u201323.","journal-title":"Am J Epidemiol"},{"issue":"50","key":"ref16","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada SD","year":"2008","unstructured":"Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proceedings of the National Academy of Sciences of the United States of America 2008; 105(50): 19887\u201392.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyx050","article-title":"Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study","author":"Adebamowo SN","year":"2017","unstructured":"Adebamowo SN, Dareng EO, Famooto AO, et al. Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study. Int J Epidemiol 2017.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9378(80)90005-8","article-title":"Myomas of the uterus in pregnancy: ultrasonographic follow-up","volume":"138","author":"Muram D","year":"1980","unstructured":"Muram D, Gillieson M, Walters JH. Myomas of the uterus in pregnancy: ultrasonographic follow-up. American journal of obstetrics and gynecology 1980; 138(1): 16\u20139.","journal-title":"American journal of obstetrics and gynecology"},{"issue":"368","key":"ref19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots","volume":"74","author":"Cleveland WS","year":"1979","unstructured":"Cleveland WS. Robust locally weighted regression and smoothing scatterplots. Journal of the American statistical association 1979; 74(368): 829\u201336.","journal-title":"Journal of the American statistical association"},{"issue":"1\u20133","key":"ref20","first-page":"14","article-title":"Epidemiology of Uterine Leiomyomata at the Lagos University Teaching Hospital, Idi-Araba, Lagos","volume":"15","author":"Oluwole A","year":"2015","unstructured":"Oluwole A, Owie E, Babah O, Afolabi B, Oye-Adeniran B. Epidemiology of Uterine Leiomyomata at the Lagos University Teaching Hospital, Idi-Araba, Lagos. Nigerian Hospital Practice 2015; 15(1\u20133): 14\u201320.","journal-title":"Nigerian Hospital Practice"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40738-016-0022-9","article-title":"Factors associated with uterine fibroid in Ghanaian women undergoing pelvic scans with suspected uterine fibroid","volume":"2","author":"Sarkodie BD","year":"2016","unstructured":"Sarkodie BD, Botwe BO, Adjei DN, Ofori E. Factors associated with uterine fibroid in Ghanaian women undergoing pelvic scans with suspected uterine fibroid. Fertility research and practice 2016a; 2(1): 1\u20137.","journal-title":"Fertility research and practice"},{"issue":"1","key":"ref22","first-page":"1","article-title":"Uterine fibroids in pregnancy: prevalence, clinical presentation, associated factors and outcomes at the Limbe and Buea Regional Hospitals, Cameroon: a cross-sectional study","volume":"11","author":"Egbe TO","year":"2018","unstructured":"Egbe TO, Badjang TG, Tchounzou R, Egbe E-N, Ngowe MN. Uterine fibroids in pregnancy: prevalence, clinical presentation, associated factors and outcomes at the Limbe and Buea Regional Hospitals, Cameroon: a cross-sectional study. BMC research notes 2018; 11(1): 1\u20136.","journal-title":"BMC research notes"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment","volume":"43","author":"Yang Q","year":"2021","unstructured":"Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocrine Reviews 2021; 43(4): 678\u2013719.","journal-title":"Endocrine Reviews"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00001648-199607000-00018","article-title":"Reproductive Factors and Risk of Uterine Fibroids","volume":"7","author":"Parazzini F","year":"1996","unstructured":"Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive Factors and Risk of Uterine Fibroids. Epidemiology 1996; 7(4): 440\u20132.","journal-title":"Epidemiology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/aje\/kwh017","article-title":"Invited Commentary: Uterine Leiomyomata\u2014We Know So Little but Could Learn So Much","volume":"159","author":"Baird DD","year":"2004","unstructured":"Baird DD. Invited Commentary: Uterine Leiomyomata\u2014We Know So Little but Could Learn So Much. American Journal of Epidemiology 2004; 159(2): 124\u20136.","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/jwh.2016.5913","article-title":"Induced and spontaneous abortion and risk of uterine fibroids","volume":"26","author":"Song L","year":"2017","unstructured":"Song L, Shen L, Mandiwa C, et al. Induced and spontaneous abortion and risk of uterine fibroids. Journal of women's health 2017; 26(1): 76\u201382.","journal-title":"Journal of women's health"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s43032-021-00656-6","article-title":"Uterine Fibroids and Pregnancy: How Do They Affect Each Other?","volume":"29","author":"Coutinho LM","year":"2022","unstructured":"Coutinho LM, Assis WA, Spagnuolo-Souza A, Reis FM. Uterine Fibroids and Pregnancy: How Do They Affect Each Other? Reproductive Sciences 2022; 29(8): 2145\u201351.","journal-title":"Reproductive Sciences"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/medicina57070717","article-title":"Impact of Contraception on Uterine Fibroids","volume":"57","author":"Kwas K","year":"2021","unstructured":"Kwas K, Nowakowska A, Fornalczyk A, et al. Impact of Contraception on Uterine Fibroids. Medicina 2021; 57(7): 717.","journal-title":"Medicina"},{"issue":"6543","key":"ref29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives","volume":"293","author":"Ross RK","year":"1986","unstructured":"Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. British Medical Journal (Clinical research ed) 1986; 293(6543): 359\u201362.","journal-title":"British Medical Journal (Clinical research ed)"},{"issue":"Suppl Suppl 1","key":"ref30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/padr.12051","article-title":"Contraceptive Practice in Sub-Saharan Africa","volume":"43","author":"Tsui AO","year":"2017","unstructured":"Tsui AO, Brown W, Li Q. Contraceptive Practice in Sub-Saharan Africa. Popul Dev Rev 2017; 43(Suppl Suppl 1): 166\u201391.","journal-title":"Popul Dev Rev"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.contraception.2012.06.007","article-title":"A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms","volume":"86","author":"Berenson AB","year":"2012","unstructured":"Berenson AB, Rahman M. A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms. Contraception 2012; 86(6): 716\u201324.","journal-title":"Contraception"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1996.tb09911.x","article-title":"Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case\u2013control study","volume":"103","author":"Lumbiganon P","year":"1996","unstructured":"Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case\u2013control study. British journal of obstetrics and gynaecology 1996; 103(9): 909\u201314.","journal-title":"British journal of obstetrics and gynaecology"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/humrep\/dev069","article-title":"Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women","volume":"30","author":"Harmon QE","year":"2015","unstructured":"Harmon QE, Baird DD. Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women. Human reproduction 2015; 30(6): 1499\u2013504.","journal-title":"Human reproduction"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/AOG.0000000000004745","article-title":"Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma","volume":"139","author":"Harmon QE","year":"2022","unstructured":"Harmon QE, Patchel SA, Zhao S, Umbach DM, Cooper TE, Baird DD. Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma. Obstet Gynecol 2022; 139(5): 797\u2013807.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.AOG.0000154161.03418.e3","article-title":"Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study","volume":"105","author":"Wise LA","year":"2005","unstructured":"Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol 2005; 105(3): 563\u20138.","journal-title":"Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1003605","DOI":"10.3389\/fmed.2022.1003605","article-title":"Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study","volume":"9","author":"Cheng LC","year":"2022","unstructured":"Cheng LC, Li HY, Gong QQ, Huang CY, Zhang C, Yan JZ. Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study. Front Med (Lausanne) 2022; 9: 1003605.","journal-title":"Front Med (Lausanne)"},{"year":"2023","author":"Lou Z","key":"ref37","unstructured":"Lou Z, Huang Y, Li S, et al. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990\u20132019: An age- period-cohort analysis for the Global Burden of Disease 2019 study. BMC Public Health 2023; Preprint"},{"year":"2020","author":"Ulin M","key":"ref38","unstructured":"Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause 2020; 27(2): 238 \u2013 42. Members of the ACCME Research Group as part of the H3Africa Consortium Clement A. Adebamowo, MD, ScD1\u20133, Sally N. Adebamowo, MD, MSc, ScD1,2, Richard Offiong, MD4, Olayinka Olaniyan, MD5, Kayode Obende, MD6, Amos Adebayo, MD7, Sanni Ologun, MD8, Bunmi Alabi, MD9; Peter Achara, MD10. Juliet Iyosaba Erhunmwonsere BSNc, RN, RM3. Yinka Owoade BSc, MSc3, Tolu Gbolahan BSc3. Members\u2019 Affiliations 1Department of Epidemiology and Public Health, and the Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, 21201, USA <supvertical-align:super;>2<\/supvertical-align:super;>Center for Bioethics and Research, Ibadan, Nigeria 3Institute of Human Virology Nigeria, Abuja, Nigeria 4University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria 5National Hospital Abuja, Abuja, Nigeria 6Garki Hospital Abuja, Abuja, Nigeria 7Asokoro District Hospital, Abuja, Nigeria 8Kubwa General Hospital Abuja, Nigeria 9Wuse General Hospital, Abuja, Nigeria 10Federal Medical Center, Keffi, Nigeria"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2917100\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2917100\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T10:27:23Z","timestamp":1699266443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2917100\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":38,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2917100\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-023-44703-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,5,18]]},"subtype":"preprint"}}